Inventor
Taekyu Lee
Inventor
Doylestown, PA, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes11%
B60KArrangement or mounting of propulsion units or of transmissions in vehicles2%
B60TVehicle brake control systems or parts thereof2%
B60WConjoint control of vehicle sub-units of different type or different function2%
C07KPeptides2%
F02DControlling combustion engines2%
F02NStarting of combustion engines2%
Y02TClimate change mitigation technologies related to transportation2%
PatentTitleYear
10,920,731Method and device for controlling vehicle including idle stop and go function202110,844,044WDR5 inhibitors and modulators202010,844,032Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors202010,807,959WDR5-MLL1 inhibitors and modulators202010,533,010Substituted indole Mcl-1 inhibitors202010,093,640Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors201810,005,728Substituted indole Mcl-1 inhibitors20189,949,965Tricyclic indole Mcl-1 inhibitors and uses thereof20187,858,639'Bicyclic heterocycles as cannabinoid-1 receptor modulators'20107,795,436'Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists'20107,632,837'Bicyclic heterocycles as cannabinoid-1 receptor modulators'20097,592,454'Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists'20097,572,808'Triazolopyridine cannabinoid receptor 1 antagonists'20097,238,690'Substituted heterocycle fused gamma-carbolines'2007RE039679'Substituted heterocycle fused gamma-carbolines'2007RE039680'Substituted heterocycle fused gamma-carbolines'20077,183,282'Substituted heterocycle fused γ-carbolines'20077,109,339'Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists'20067,081,455'Substituted heterocycle fused gamma-carbolines'20067,071,186'Substituted heterocycle fused gamma-carbolines'20066,849,619'Substituted pyridoindoles as serotonin agonists and antagonists'20056,803,466'HIV/FIV protease inhibitors having a small P3 residue'20046,777,406'Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists'20046,713,471'Substituted heterocycle fused gamma-carbolines'20046,699,852'Substituted pyridoindoles as serotonin agonists and antagonists'20046,638,934'Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands'20036,552,017'Substituted heterocycle fused gamma-carbolines'20036,548,493'Substituted heterocycle fused gamma-carbolines'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2007Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (10)· patent assignee history
2003–2007Based in Wilmington, DE, US· patent location history
2005–2010Patents assigned to BRISTOL MYERS SQUIBB CO (9)· patent assignee history
2005–2010Based in Doylestown, PA, US· patent location history
2018–2020Patents assigned to UNIV VANDERBILT (7)· patent assignee history
2018–2020Based in Brentwood, TN, US· patent location history
2021Patents assigned to HYUNDAI MOTOR CO LTD (1)· patent assignee history
2021Patents assigned to KIA MOTORS CORP (1)· patent assignee history
2021Based in Hwaseong-si, KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB PHARMA CO | 10 | 2003–2007 |
| BRISTOL MYERS SQUIBB CO | 9 | 2005–2010 |
| UNIV VANDERBILT | 7 | 2018–2020 |
| HYUNDAI MOTOR CO LTD | 1 | 2021 |
| KIA MOTORS CORP | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Doylestown, Pennsylvania, US | 11 | 2005–2010 |
| Wilmington, Delaware, US | 9 | 2003–2007 |
| Brentwood, TN, US | 7 | 2018–2020 |
| Hwaseong-si, KR | 1 | 2021 |